TY - JOUR
T1 - Tuberous sclerosis tumor suppressor complex-like complexes act as GTPase-activating proteins for Ral GTPases
AU - Shirakawa, Ryutaro
AU - Fukai, Shuya
AU - Kawato, Mitsunori
AU - Higashi, Tomohito
AU - Kondo, Hirokazu
AU - Ikeda, Tomoyuki
AU - Nakayama, Ei
AU - Okawa, Katsuya
AU - Nureki, Osamu
AU - Kimura, Takeshi
AU - Kita, Toru
AU - Horiuchi, Hisanori
PY - 2009/8/7
Y1 - 2009/8/7
N2 - The small GTPases RalA and RalB are multifunctional proteins regulating a variety of cellular processes. Like other GTPases, the activity of Ral is regulated by the opposing effects of guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs). Although several RalGEFs have been identified and characterized, the molecular identity of RalGAP remains unknown. Here, we report the first molecular identification of RalGAPs, which we have named RalGAP1 and RalGAP2. They are large heterodimeric complexes, each consisting of a catalytic α1 or α2 subunit and a common β subunit. These RalGAP complexes share structural and catalytic similarities with the tuberous sclerosis tumor suppressor complex, which acts as a GAP for Rheb. In vitro GTPase assays revealed that recombinant RalGAP1 accelerates the GTP hydrolysis rate of RalA by 280,000-fold. Heterodimerization was required for this GAP activity. In PC12 cells, knockdown of the β subunit led to sustained Ral activation upon epidermal growth factor stimulation, indicating that the RalGAPs identified here are critical for efficient termination of Ral activation induced by extracellular stimuli. Our identification of RalGAPs will enable further understanding of Ral signaling in many biological and pathological processes.
AB - The small GTPases RalA and RalB are multifunctional proteins regulating a variety of cellular processes. Like other GTPases, the activity of Ral is regulated by the opposing effects of guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs). Although several RalGEFs have been identified and characterized, the molecular identity of RalGAP remains unknown. Here, we report the first molecular identification of RalGAPs, which we have named RalGAP1 and RalGAP2. They are large heterodimeric complexes, each consisting of a catalytic α1 or α2 subunit and a common β subunit. These RalGAP complexes share structural and catalytic similarities with the tuberous sclerosis tumor suppressor complex, which acts as a GAP for Rheb. In vitro GTPase assays revealed that recombinant RalGAP1 accelerates the GTP hydrolysis rate of RalA by 280,000-fold. Heterodimerization was required for this GAP activity. In PC12 cells, knockdown of the β subunit led to sustained Ral activation upon epidermal growth factor stimulation, indicating that the RalGAPs identified here are critical for efficient termination of Ral activation induced by extracellular stimuli. Our identification of RalGAPs will enable further understanding of Ral signaling in many biological and pathological processes.
UR - http://www.scopus.com/inward/record.url?scp=69249109593&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=69249109593&partnerID=8YFLogxK
U2 - 10.1074/jbc.M109.012112
DO - 10.1074/jbc.M109.012112
M3 - Article
C2 - 19520869
AN - SCOPUS:69249109593
SN - 0021-9258
VL - 284
SP - 21580
EP - 21588
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 32
ER -